SILVER SPRING, MD / ACCESS Newswire / March 16, 2026 / CuriosityStream, Inc. (the "Company") (Nasdaq:CURI), a leading global factual entertainment media company, today announced that Clint Stinchcomb, ...
The average credit score in the U.S. rose during the pandemic, then slipped as debt and missed payments grew. Find out what ...
Accounts like 401(k)s and traditional IRAs have up-front tax breaks that allow you to deduct your contributions from your taxable income. In return, you're required to pay taxes on the withdrawals you ...
A Bloomberg gauge of its performance turned negative for the year at the end of last week, after losing 1.7% this month. With ...
MCLEAN, VA / ACCESS Newswire / March 16, 2026 / Cycurion, Inc. (Nasdaq:CYCU), a leading provider of AI-driven cybersecurity solutions for critical infrastructure, today announced it has entered into a ...
CEO Jensen Huang will hold his annual keynote at the company’s GTC event in San Jose, Calif., on Monday. Huang is expected to spend his roughly two-hour speech providing deeper insights into the state ...
Bernstein said in a note Monday that it sees a potential 20% upside in Taiwan Semiconductor shares, saying the chipmaker’s growth outlook remains intact despite the conflict in the Middle East.
Oil prices rose Monday following further attacks on Middle East oil facilities and after the White House suggested the war ...
Amsterdam-based AI infrastructure firm Nebius Group said Monday it has signed a five-year deal with Meta Platforms to provide the social media ...
Chartwell Retirement Residences ("Chartwell") (TSX: CSH.UN) announced today a cash distribution of $0.052 per Trust Unit. The cash distribution will be payable on April 15, 2026, to unitholders of ...
Most Americans believe they need roughly $1.28 million to retire comfortably, according to Schroders (1). So it’s easy to assume that if you have nearly twice as much — or $2 million — you would ...
Placebo-adjusted mean weight loss of 16.3% (39 lbs) at 180 mg and 16.0% (37 lbs) at 240 mg at 44 weeks with no evidence of weight loss plateau in ACCESS II, demonstrating highest efficacy among oral ...